Live Biotherapeutics Market (Therapeutic Area: Gastrointestinal Disorders, Metabolic Disorders, Dermatological Diseases, and Others (Cancer, Genito-urinary, Mental Health etc.); and Route of Administration: Oral, Rectal, and Others (Topical etc.) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
Live Biotherapeutics Market – Scope of Report TMR’s report on the global live biotherapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insigh... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryLive Biotherapeutics Market – Scope of ReportTMR’s report on the global live biotherapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global live biotherapeutics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global live biotherapeutics market from 2024 to 2034. The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the live biotherapeutics market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global live biotherapeutics market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global live biotherapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global live biotherapeutics market. The report delves into the competitive landscape of the global live biotherapeutics market. Key players operating in the global live biotherapeutics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global live biotherapeutics market profiled in this report. Key Questions Answered in Global live biotherapeutics Market Report • What is the sales/revenue generated by live biotherapeutics across all regions during the forecast period? • What are the opportunities in the global live biotherapeutics market? • What are the major drivers, restraints, opportunities, and threats in the market? • Which regional market is set to expand at the fastest CAGR during the forecast period? • Which segment is expected to generate the highest revenue globally in 2034? • Which segment is projected to expand at the highest CAGR during the forecast period? • What are the market positions of different companies operating in the global market? Live Biotherapeutics Market – Research Objectives and Research Approach The comprehensive report on the global live biotherapeutics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. The report analyzes the global live biotherapeutics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global live biotherapeutics market. Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Live Biotherapeutics Market 4. Market Overview 4.1. Introduction 4.1.1. Segment Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Live Biotherapeutics Market Analysis and Forecast, 2020-2034 5. Key Insights 5.1. Pipeline Analysis 5.2. Epidemiology of Clostridium Difficile Infection 5.3. Insights on Trends in the U.S. Burden of Clostridioides Difficile Infection 5.4. Porters' Five Forces Analysis 6. Global Live Biotherapeutics Market Analysis and Forecast, By Therapeutic Area 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast By Therapeutic Area, 2020-2034 6.3.1. Gastrointestinal Disorders 6.3.2. Metabolic Disorders 6.3.3. Dermatological Diseases 6.3.4. Others 6.4. Market Attractiveness By Therapeutic Area 7. Global Live Biotherapeutics Market Analysis and Forecast, By Route of Administration 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast By Route of Administration, 2020-2034 7.3.1. Oral 7.3.2. Rectal 7.3.3. Others (Topical etc.) 7.4. Market Attractiveness By Route of Administration 8. Global Live Biotherapeutics Market Analysis and Forecast, By Distribution Channel 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast By Distribution Channel, 2020-2034 8.3.1. Hospital Pharmacies 8.3.2. Retail Pharmacies 8.3.3. Online Pharmacies 8.4. Market Attractiveness By Distribution Channel 9. Global Live Biotherapeutics Market Analysis and Forecast, By Region 9.1. Key Findings 9.2. Market Value Forecast By Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness By Country/Region 10. North America Live Biotherapeutics Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast By Therapeutic Area, 2020-2034 10.2.1. Gastrointestinal Disorders 10.2.2. Metabolic Disorders 10.2.3. Dermatological Diseases 10.2.4. Others 10.3. Market Value Forecast By Route of Administration, 2020-2034 10.3.1. Oral 10.3.2. Rectal 10.3.3. Others (Topical etc.) 10.4. Market Value Forecast By Distribution Channel, 2020-2034 10.4.1. Hospital Pharmacies 10.4.2. Retail Pharmacies 10.4.3. Online Pharmacies 10.5. Market Value Forecast By Country, 2020-2034 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Therapeutic Area 10.6.2. By Route of Administration 10.6.3. By Distribution Channel 10.6.4. By Country 11. Europe Live Biotherapeutics Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast By Therapeutic Area, 2030-2034 11.2.1. Gastrointestinal Disorders 11.2.2. Metabolic Disorders 11.2.3. Dermatological Diseases 11.2.4. Others 11.3. Market Value Forecast By Route of Administration, 2030-2034 11.3.1. Oral 11.3.2. Rectal 11.3.3. Others (Topical etc.) 11.4. Market Value Forecast By Distribution Channel, 2030-2034 11.4.1. Hospital Pharmacies 11.4.2. Retail Pharmacies 11.4.3. Online Pharmacies 11.5. Market Value Forecast By Country, 2030-2034 11.5.1. Germany 11.5.2. U.K. 11.5.3. France 11.5.4. Italy 11.5.5. Spain 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Therapeutic Area 11.6.2. By Route of Administration 11.6.3. By Distribution Channel 11.6.4. By Country 12. Asia Pacific Live Biotherapeutics Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast By Therapeutic Area, 2031-2034 12.2.1. Gastrointestinal Disorders 12.2.2. Metabolic Disorders 12.2.3. Dermatological Diseases 12.2.4. Others 12.3. Market Value Forecast By Route of Administration, 2031-2034 12.3.1. Oral 12.3.2. Rectal 12.3.3. Others (Topical etc.) 12.4. Market Value Forecast By Distribution Channel, 2031-2034 12.4.1. Hospital Pharmacies 12.4.2. Retail Pharmacies 12.4.3. Online Pharmacies 12.5. Market Value Forecast By Country, 2031-2034 12.5.1. China 12.5.2. India 12.5.3. Japan 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Therapeutic Area 12.6.2. By Route of Administration 12.6.3. By Distribution Channel 12.6.4. By Country 13. Latin America Live Biotherapeutics Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast By Therapeutic Area, 2032-2034 13.2.1. Gastrointestinal Disorders 13.2.2. Metabolic Disorders 13.2.3. Dermatological Diseases 13.2.4. Others 13.3. Market Value Forecast By Route of Administration, 2032-2034 13.3.1. Oral 13.3.2. Rectal 13.3.3. Others (Topical etc.) 13.4. Market Value Forecast By Distribution Channel, 2032-2034 13.4.1. Hospital Pharmacies 13.4.2. Retail Pharmacies 13.4.3. Online Pharmacies 13.5. Market Value Forecast By Country, 2032-2034 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Therapeutic Area 13.6.2. By Route of Administration 13.6.3. By Distribution Channel 13.6.4. By Country 14. Middle East & Africa Live Biotherapeutics Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast By Therapeutic Area, 2032-2034 14.2.1. Gastrointestinal Disorders 14.2.2. Metabolic Disorders 14.2.3. Dermatological Diseases 14.2.4. Others 14.3. Market Value Forecast By Route of Administration, 2032-2034 14.3.1. Oral 14.3.2. Rectal 14.3.3. Others (Topical etc.) 14.4. Market Value Forecast By Distribution Channel, 2032-2034 14.4.1. Hospital Pharmacies 14.4.2. Retail Pharmacies 14.4.3. Online Pharmacies 14.5. Market Value Forecast By Country, 2032-2034 14.5.1. GCC 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Therapeutic Area 14.6.2. By Route of Administration 14.6.3. By Distribution Channel 14.6.4. By Country 15. Competition Landscape 15.1. Market Player - Competition Matrix (By Tier and Size of companies) 15.2. Market Share Analysis By Company (2023) 15.3. Company Profiles 15.3.1. Ferring Pharmaceuticals 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.1.2. Product Portfolio 15.3.1.3. Financial Overview 15.3.1.4. SWOT Analysis 15.3.1.5. Strategic Overview 15.3.2. Seres Therapeutics 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2.2. Product Portfolio 15.3.2.3. Financial Overview 15.3.2.4. SWOT Analysis 15.3.2.5. Strategic Overview 15.3.3. Rebiotix Inc. 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.3.2. Product Portfolio 15.3.3.3. Financial Overview 15.3.3.4. SWOT Analysis 15.3.3.5. Strategic Overview 15.3.4. 4D Pharma 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.4.2. Product Portfolio 15.3.4.3. Financial Overview 15.3.4.4. SWOT Analysis 15.3.4.5. Strategic Overview 15.3.5. Finch Therapeutics 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.5.2. Product Portfolio 15.3.5.3. Financial Overview 15.3.5.4. SWOT Analysis 15.3.5.5. Strategic Overview 15.3.6. Vedanta Biosciences 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.6.2. Product Portfolio 15.3.6.3. Financial Overview 15.3.6.4. SWOT Analysis 15.3.6.5. Strategic Overview 15.3.7. Synthetic Biologics 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.7.2. Product Portfolio 15.3.7.3. Financial Overview 15.3.7.4. SWOT Analysis 15.3.7.5. Strategic Overview 15.3.8. MaaT Pharma 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.8.2. Product Portfolio 15.3.8.3. Financial Overview 15.3.8.4. SWOT Analysis 15.3.9. Enterome 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.9.2. Product Portfolio 15.3.9.3. Financial Overview 15.3.9.4. SWOT Analysis 15.3.10. Second Genome 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.10.2. Product Portfolio 15.3.10.3. Financial Overview 15.3.10.4. SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
Transparency Market Research 社の最新刊レポート
本レポートと同じKEY WORD(cancer)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/24 10:26 144.74 円 161.12 円 195.86 円 |